SYNG Pharmaceuticals

SYNG Pharmaceuticals

SYNG Pharmaceuticals (SYNG Pharma), is a pre-clinical stage Biotechnology company dedicated to developing new ‘first-in-class’ diagnostic accompanied therapeutics for endometriosis and castration resistant prostate cancer.

Area of focus: 
Oncology
Graduation date: 
02/28/2018
Commencement date: 
06/01/2016

Contact

  • Vinay Singh

    Founder & CEO

Share